HIF1A and neoplasm: Using RT-qPCR and ELISA methods, we aim to evaluate whether the expression of mRNA in blood and tumor tissue and circulating protein of CAIX and HIF1A (along with established risk factors) have potentials to predict survival in treatment-naïve Indonesian with locally-advanced (LABC) and metastatic breast cancer (MBC).